CVR: 39359340
Amicus Therapeutics ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Richard Gideon Morris. The company is owned by Amicus Therapeutics UK Ltd.. The company has 2 employees. In 2025, the company reported a gross profit of DKK 1,441,140 and a net result of DKK 115,004 compared with DKK 16,475 the year before. Equity amounted to DKK 424,641.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at markedsføre, distribuere og sælge produkter og tjenesteydelser.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Amicus Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK 1,441,140, and the net result was DKK 115,004.
As of June 17, 2026, Richard Gideon Morris has joined the board of directors of Amicus Therapeutics ApS.
As of June 17, 2026, Brian Keogh has joined the board of directors of Amicus Therapeutics ApS.
As of June 17, 2026, Jessica Alice Stephens-Brown has left the board of directors of Amicus Therapeutics ApS.
As of June 17, 2026, Ana Rogovic has left the board of directors of Amicus Therapeutics ApS.
As of June 17, 2026, Richard Gideon Morris is registered as director of Amicus Therapeutics ApS.
As of June 17, 2026, Ana Rogovic has stepped down as director of Amicus Therapeutics ApS.
Amicus Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK 1,987,087, and the net result was DKK 16,475.
As of October 7, 2024, Jessica Alice Stephens-Brown has joined the board of directors of Amicus Therapeutics ApS.
As of October 7, 2024, Ana Rogovic has joined the board of directors of Amicus Therapeutics ApS.
As of October 7, 2024, Charlotte Ann Galvin has left the board of directors of Amicus Therapeutics ApS.
As of October 7, 2024, David Malcolm Lewis has left the board of directors of Amicus Therapeutics ApS.
As of October 7, 2024, Ana Rogovic is registered as director of Amicus Therapeutics ApS.
As of October 7, 2024, Charlotte Ann Galvin has stepped down as director of Amicus Therapeutics ApS.
Amicus Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK 1,732,212, and the net result was DKK 52,221.
As of February 1, 2024, David Malcolm Lewis has joined the board of directors of Amicus Therapeutics ApS.
As of January 31, 2024, Anita Jane Clifford has left the board of directors of Amicus Therapeutics ApS.
Amicus Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK 1,575,511, and the net result was DKK 54,033.
As of May 24, 2023, Charlotte Ann Galvin has joined the board of directors of Amicus Therapeutics ApS.
As of May 24, 2023, Charlotte Ann Galvin is registered as director of Amicus Therapeutics ApS.
As of March 17, 2023, John Erik Mattias Bankel has left the board of directors of Amicus Therapeutics ApS.
As of March 17, 2023, John Erik Mattias Bankel has stepped down as director of Amicus Therapeutics ApS.
Amicus Therapeutics ApS has published its annual report for 2021. Gross profit came to DKK 644,168, and the net result was DKK 19,351.
Amicus Therapeutics ApS has published its annual report for 2020. Gross profit came to DKK 490,223, and the net result was DKK 21,886.
As of May 3, 2021, Steven John Green has joined the board of directors of Amicus Therapeutics ApS.
As of May 3, 2021, Nicole Ruth Reichman has left the board of directors of Amicus Therapeutics ApS.
Amicus Therapeutics ApS has published its annual report for 2019. Gross profit came to DKK 2,019,085, and the net result was DKK 84,291.
As of February 28, 2020, John Erik Mattias Bankel has joined the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Anita Jane Clifford has joined the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Nicole Ruth Reichman has joined the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Johnny Krogh Hansen has left the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Simon Collins has left the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, Lori Mochan has left the board of directors of Amicus Therapeutics ApS.
As of February 28, 2020, John Erik Mattias Bankel is registered as director of Amicus Therapeutics ApS.
As of February 28, 2020, Johnny Krogh Hansen has stepped down as director of Amicus Therapeutics ApS.
Amicus Therapeutics ApS has published its interim report for the period February 23, 2018 – December 31, 2018.
As of February 12, 2019, Detlef Wolff has left the board of directors of Amicus Therapeutics ApS.
As of July 6, 2018, Detlef Wolff has joined the board of directors of Amicus Therapeutics ApS.
As of July 6, 2018, Lori Mochan has joined the board of directors of Amicus Therapeutics ApS.
As of July 6, 2018, Jasvinder Sarkaria has left the board of directors of Amicus Therapeutics ApS.
As of February 23, 2018, Johnny Krogh Hansen has joined the board of directors of Amicus Therapeutics ApS.
As of February 23, 2018, Simon Collins has joined the board of directors of Amicus Therapeutics ApS.
As of February 23, 2018, Jasvinder Sarkaria has joined the board of directors of Amicus Therapeutics ApS.
As of February 23, 2018, Johnny Krogh Hansen is registered as director of Amicus Therapeutics ApS.
As of February 23, 2018, is registered as an owner of Amicus Therapeutics ApS with an ownership share of 100%.
Amicus Therapeutics ApS was founded on February 23, 2018.
Companies in the same industry and area
CVR 37626619
CVR 41183144
CVR 35451307
CVR 36392398
CVR 14479880
companydata.dk